131 related articles for article (PubMed ID: 19729946)
21. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
[TBL] [Abstract][Full Text] [Related]
22. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.
van Nieuwpoort IC; Sinnema M; Castelijns JA; Twisk JW; Curfs LM; Drent ML
Horm Res Paediatr; 2011; 75(6):403-11. PubMed ID: 21273761
[TBL] [Abstract][Full Text] [Related]
23. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
24. [Ovarian function in young women after anticancer treatment in childhood].
Krawczuk-Rybak M; Leszczyńska E; Zelazowska-Rutkowska B; Wysocka J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1028-34. PubMed ID: 19531821
[TBL] [Abstract][Full Text] [Related]
25. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
[TBL] [Abstract][Full Text] [Related]
26. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
[TBL] [Abstract][Full Text] [Related]
27. Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.
Soto N; Iñiguez G; López P; Larenas G; Mujica V; Rey RA; Codner E
Hum Reprod; 2009 Nov; 24(11):2838-44. PubMed ID: 19643804
[TBL] [Abstract][Full Text] [Related]
28. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
30. [Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women].
Ohl J; Partisani M; Demangeat C; Binder-Foucard F; Nisand I; Lang JM
Gynecol Obstet Fertil; 2010 May; 38(5):313-7. PubMed ID: 20430670
[TBL] [Abstract][Full Text] [Related]
31. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
32. The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea.
Jonard S; Pigny P; Jacquesson L; Demerle-Roux C; Robert Y; Dewailly D
Hum Reprod; 2005 Jan; 20(1):101-7. PubMed ID: 15513979
[TBL] [Abstract][Full Text] [Related]
33. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
[TBL] [Abstract][Full Text] [Related]
34. Hypogonadism and pubertal development in Prader-Willi syndrome.
Crinò A; Schiaffini R; Ciampalini P; Spera S; Beccaria L; Benzi F; Bosio L; Corrias A; Gargantini L; Salvatoni A; Tonini G; Trifirò G; Livieri C;
Eur J Pediatr; 2003 May; 162(5):327-33. PubMed ID: 12692714
[TBL] [Abstract][Full Text] [Related]
35. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
36. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
[TBL] [Abstract][Full Text] [Related]
37. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.
Tran ND; Cedars MI; Rosen MP
J Clin Endocrinol Metab; 2011 Dec; 96(12):3609-14. PubMed ID: 21937624
[TBL] [Abstract][Full Text] [Related]
38. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
Chu MC; Carmina E; Wang J; Lobo RA
Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
[TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
40. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
